LabPulse.com

Lab News

FDA approves marketing of BioFire COVID-19 test
March 18, 2021 -- The U.S. Food and Drug Administration (FDA) announced it has granted marketing approval for the BioFire Respiratory Panel 2.1 (RP2.1), a diagnostic test for the simultaneous qualitative detection and identification of multiple respiratory viral and bacterial nucleic acids in nasopharyngeal swabs obtained from individuals suspected of COVID-19 and other respiratory tract infections. Read More

Inflammatix secures $102M in financing
March 16, 2021 -- Molecular diagnostics firm Inflammatix has secured $102 million in financing that it plans to use to commercialize its novel immune response diagnostics portfolio. Read More

Variantyx obtains $20M in funding
March 16, 2021 -- Hereditary disease testing provider Variantyx has obtained $20M in funding for its whole genome sequencing-based testing method. Read More

Roche signs $1.8B acquisition agreement with GenMark
March 16, 2021 -- Roche has inked a $1.8 billion acquisition agreement with GenMark Diagnostics. The deal is expected to close in the second quarter of this year. Read More

Euroimmun launches new diagnostic microscope
March 16, 2021 -- PerkinElmer subsidiary Euroimmun has released EuroPattern Microscope Live, a compact immunofluorescence microscope available with the fourth generation of its EuroLabOffice 4.0 laboratory management software. Read More

Estrogen receptor tied to outcomes in DCIS
March 16, 2021 -- The estrogen receptor plays a key role in predicting long-term outcomes in patients with ductal carcinoma in situ (DCIS), researchers from Queen Mary University of London reported in a study published online March 16 in Clinical Cancer Research. Read More

Veracyte completes Decipher acquisition for $600M
March 15, 2021 -- Veracyte has completed a $600 million cash deal to acquire Decipher Biosciences, expanding its position in the genomics-driven cancer diagnostics sector. Decipher Biosciences is now a subsidiary of Veracyte. Read More

Expanding NIPT coverage means nominal cost increase
March 12, 2021 -- Expanding noninvasive prenatal testing (NIPT) for pregnant women under the age of 35 only increased Harvard Pilgrim Health Care's costs by less than $0.03 per member per month, according to a new study published on March 11 in PharmacoEconomics. Read More

Proscia, Ibex support pathologists in detecting prostate cancer
March 12, 2021 -- Proscia and Ibex Medical Analytics are teaming up to support pathologists in detecting prostate cancer through the use of artificial intelligence software. Read More

Labs still struggling with COVID-19 supplies CAP finds
March 12, 2021 -- Close to half (45%) of laboratories testing for COVID-19 have difficulties obtaining the testing supplies they need, according to a survey by the College of American Pathologists (CAP). Read More

« prev 1 2 3 4…175 next »

Webinars/Videos